VolitionRx Ltd

VNRX

Market cap $12M

VNRX Hedge Fund Activity: Q1 2026 in Review

31 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2026, worth a combined $4.52M — up 9.5% from $4.13M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new VNRX positions and 8 closed out — a net gain of 4 holders — while 10 added to existing stakes and 1 trimmed.

The largest buyer was Lagoda Investment Management, adding an estimated $1.12M. The largest seller was Citadel Advisors, exiting entirely with an estimated $42.9K sold.

• 31 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2026, up from 28 in Q4 2025.
• Funds reported $4.52M of VolitionRx Ltd stock for Q1 2026, up 9.5% quarter-over-quarter.
• 12 funds opened new VolitionRx Ltd positions in Q1 2026 and 8 closed out, a net change of +4 holders.
• The largest VolitionRx Ltd buyer in Q1 2026 was Lagoda Investment Management, an estimated $1.12M added.
• The largest VolitionRx Ltd seller in Q1 2026 was Citadel Advisors, an estimated $42.9K sold.

Based on aggregated 13F filings for Q1 2026.